[JDerm] Teledermatology Within Correctional Settings in the United States: A Narrative Review of the Literature
JMIR Publications sent this email to their subscribers on May 27, 2023.
|
|
Text-only version of this email
3 0 JMIR Dermatology
JMIR Publications
Content Update Alert, Friday 26th May 2023
RECENTLY PUBLISHED
TELEDERMATOLOGY WITHIN CORRECTIONAL SETTINGS IN THE UNITED STATES: A NARRATIVE REVIEW OF THE LITERATURE
Samir Kamat, Aneesh Agarwal, Timothy Klufas, Saahil Patel, Jun Lu
Source: Freepik; Copyright: Freepik; URL:
License: Licensed by JMIR.
JMIR Dermatol 2023 (May 26); 6(1):e47115
HTML (open access):
PDF (free):
Facebook Twitter
EVOLUTION OF A PROJECT TO IMPROVE INPATIENT-TO-OUTPATIENT DERMATOLOGY CARE TRANSITIONS: MIXED METHODS EVALUATION
Samantha M R Kling, Maria A Aleshin, Erika A Saliba-Gustafsson, Donn W Garvert, Cati G Brown-Johnson, Alexis Amano, Bernice Y
Kwong, Ana Calugar, Jonathan G Shaw, Justin M Ko, Marcy Winget
Source: freepik; Copyright: freepik; URL:
License: Licensed by JMIR.
JMIR Dermatol 2023 (May 25); 6(1):e43389
HTML (open access):
PDF (free):
Background: In-hospital dermatological care has shifted from dedicated dermatology wards to consultation services, and some
consulted patients may require postdischarge follow-up in outpatient dermatology. Safe and timely care transitions from
inpatient-to-outpatient specialty care are critical for patient health, but communication around these transitions can be
disjointed, and workflows can be complex.
Objective: In this 3-phase quality improvement effort, we developed and evaluated an intervention that leveraged an electronic
health record (EHR) feature, known as SmartPhrase, to enable a new workflow to improve transitions from inpatient care to
outpatient dermatology...
read more Facebook Twitter
STORE-AND-FORWARD TELEDERMATOLOGY FOR ASSESSING SKIN CANCER IN 2023: LITERATURE REVIEW
Leah Kirsten Jones, Amanda Oakley
Store-and-forward teledermatology at Waikato Hospital. Source: Image created by the authors; Copyright: The Authors; URL:
JMIR Dermatol 2023 (May 17); 6(1):e43395
HTML (open access):
PDF (free):
Background: The role of teledermatology for skin lesion assessment has been a recent development, particularly, since the COVID-19
pandemic has impacted the ability to assess patients in person. The growing number of studies relating to this area reflects the
evolving interest.
Objective: This literature review aims to analyze the available research on store-and-forward teledermatology for skin lesion
assessment...
read more Facebook Twitter
CONSENSUS GUIDELINES FOR TELEDERMATOLOGY: SCOPING REVIEW
Mollie R Cummins, Triton Ong, Julia Ivanova, Janelle F Barrera, Hattie Wilczewski, Hiral Soni, Brandon M Welch, Brian E Bunnell
Source: Freepik; Copyright: Drazen Zigic; URL:
License: Licensed by JMIR.
JMIR Dermatol 2023 (May 15); 6(1):e46121
HTML (open access):
PDF (free):
Background: Consensus guidelines and recommendations play an important role in fostering quality, safety, and best practices, as
they represent an expert interpretation of the biomedical literature and its application to practice. However, it is unclear
whether the recent collective experience of implementing telemedicine and the concurrent growth in the evidence base for
teledermatology have resulted in more robust guidance.
Objective: The objective of this review was to describe the extent and nature of currently available guidance, defined as
consensus guidelines and recommendations available for telemedicine in dermatology, with guidance defined as consensus or
evidence-based guidelines, protocols, or recommendations...
read more Facebook Twitter
DERMATOLOGY JOURNALS’ EDITORIAL BOARDS REQUIRE IMPROVED GENDER EQUITY: JMIR DERMATOLOGY’S FUTURE DIRECTIONS
Sarah Minion, Julianne Kiene, Robert Dellavalle
Source: Freepik; Copyright: Freepik; URL:
License: Licensed by JMIR.
JMIR Dermatol 2023 (May 05); 6(1):e43256
HTML (open access):
PDF (free):
Gender disparities exist across all facets of academic medicine including within the editorial boards of dermatology journals.
Only 22% of these editorial boards comprised women, even though 51% of full-time, faculty dermatologists are female. When inviting
academic dermatologists to our editorial board at JMIR Dermatology, we invited 50% women to represent the gender distribution of
academic dermatologists; however, we have not sufficiently reached gender equity among accepted editorial board members. We will
continue to strive toward the goal of gender equity on our editorial board and invite other dermatology journals to do the same.
Facebook Twitter
LATEST ANNOUNCEMENTS
View All
Call for Papers: Theme Issue: International Society of Teledermatology (ISTD) World Congress 2023
Teledermatology has been increasingly gaining recognition as a means of delivering dermatological care at a distance, thereby
expanding access to specialized care for patients in remote and underserved areas. This theme issue will provide a platform for
researchers and practitioners to present their work on the latest advancements and best practices in the field.JMIR
Dermatology—the official journal of the International Society of Teledermatology (ISTD)—and the journal’s guest editors welcome
submissions to a special theme issue to coincide with the 10th ISTD World Congress held at the 23rd World Congress of Dermatology
on July 4 to 7, 2023, in Singapore. This theme issue will allow attendees of the ISTD World Congress to share their work with a
wider audience by disseminating their work in a well-respected, peer-reviewed, open-access journal. We invite original submissions
of high-quality work on the discussion and sharing of knowledge, experimental work, and scientific and technical results related
to...
read more Facebook Twitter
JMIR Dermatology has passed the Scientific Quality Review by NLM for PMC
JMIR Publications is pleased to announce that JMIR Dermatology (Editor-in-Chief Dr. Robert Dellavalle) has passed the Scientific
Quality Review by the US National Library of Medicine (NLM) for PubMed Central (PMC). This decision reflects the scientific and
editorial quality of the journal. All articles published from 2021 onward will be found on PMC and PubMed after their technical
evaluation. Launched in 2018, JMIR Dermatology is a general dermatology journal that focuses on all topics related to diseases of
the skin, hair, and nails, with special emphasis on technologies for information exchange, education, and clinical care. Facebook
Twitter
Call for Papers for a New Theme Issue (2022): Celebrating Cochrane Skin: 25 Years of Evidence-Based Dermatology
JMIR Dermatology editor in chief Robert Dellavalle, MSPH, MD, PhD, and the editorial board welcome submissions to a special theme
issue celebrating the 25th anniversary milestone of the Cochrane Skin Group and reflecting on the achievements and impact of the
work of Cochrane Skin authors. Since its inception, Cochrane Skin has published over 125 systematic reviews on a broad range of
interventions and conditions, many of which are cited in internationally recognized guidelines.This JMIR Dermatology theme issue
calls for research letters or viewpoints highlighting the findings and influence of high-impact Cochrane Skin reviews. Authors can
summarize findings from their Cochrane reviews (see JDerm’s Cochrane Corner for examples) or provide a broader commentary on the
impact of the review on the field.JMIR Publications will not charge any article processing fees for these submissions.All articles
submitted to this theme issue will be shared and published rapidly through the following mechanisms:JMIR Preprints are...
read more Facebook Twitter
LATEST SUBMISSIONS OPEN TO PEER REVIEW
View All
A clinical comparative study of an intelligent IoT-based HFNC device to provide respiratory support for patients with acute
respiratory failure:a multi-center prospective controlled study
Yixiang Zhang, Yinfeng Wang, Qingquan Chen, Jiajing Zhuang, Huaxian Zheng, Haibin Lu, Chunfa Zhang, Jinzhen Ding, Liyong Shi,
Xiaoping Lin, Weijing Wu, Xiaoyang Chen
Date Submitted: May 22, 2023
Open Peer Review Period: May 21, 2023 - Jul 16, 2023
Background: The prevalence of respiratory diseases has increased significantly, resulting in a rise in the use of high-flow nasal
cannula (HFNC) therapy. However, certain limitations still exist in the clinical practice of HFNC therapy, such as prolonged
equipment training and limited healthcare resources, which can lead to unforeseen emergencies. Fortunately, with the advent of
Internet of Things (IoT) technology, great potential has emerged for developing novel solutions for medical equipment management
to overcome these challenges. By integrating technology, information, and services, the IoT-based HFNC equipment and remote
management platform can provide real-time patient monitoring, timely adjustments, and early warnings for respiratory failure,
leading to improved clinical outcomes and economic benefits. Therefore, our study explored the use of these innovative
technologies in enhancing clinical effectiveness and resource use.
Methods: In this study, we developed a remote management platform for respiratory equipment using the latest Internet of Things
(IoT) and big data analysis technologies. Data on patients treated with high-flow nasal cannulas (HFNCs) were collected from 12
medical institutions in Fujian Province from December 2020 to December 2022. Patients were randomly allocated to either the
ordinary HFNC group or the intelligent HFNC group. Basic patient information, medical history, laboratory indicators, total
hospitalization costs and duration, comfort level, dryness score, and cough disorder scores were all recorded. The two groups were
compared using the t tests and chi-square tests, and a P value of less than .05 was considered statistically significant. Advanced
statistical methods were employed to ensure that the data were accurately analyzed and that the results were valid and reliable.
Overall, we applied the latest scientific approaches and technologies to ensure the highest-quality data and analysis.
Results: A total of 619 patients were enrolled in this study, with no statistically significant differences between the ordinary
HFNC group and the intelligent HFNC group in terms of general information. However, the use of intelligent HFNCs was associated
with a significantly reduced hospitalization cost and duration compared to the ordinary HFNC group. Furthermore, patients using
intelligent HFNCs reported consistently lower levels of dryness and rated higher in terms of comfort compared to those using
ordinary HFNCs. There were no statistically significant differences in blood oxygen level, complications, clinical outcome,
impaired coughing, dyspnea, or assisted respiratory muscle mobilization between the two groups. Overall, our findings suggested
that the use of intelligent HFNCs may be a promising and effective solution for the management of respiratory diseases, with
potential benefits for both patients and healthcare systems.
Conclusions: We successfully developed a remote management platform for respiratory equipment using Internet of Things (IoT)
technology and big data analysis, with the intelligent high-flow nasal cannula (HFNC) as the core. Our findings indicated that
patients who received treatment with the intelligent HFNC experienced improved comfort, shorter hospital stays, and reduced
hospitalization costs compared to those who received traditional HFNC treatment. This platform not only provided precise oxygen
therapy to patients with respiratory failure, but also supported physicians in analyzing conditions, enacting parameter settings,
and issuing early sickness warnings. Consequently, the integration of IoT technology with intelligent HFNCs holds great potential
in terms of cost and resource management and may present advantages compared to traditional HFNC methods.
add me as a reviewer Facebook Twitter
Evaluation of Arabic Web-Based Resources on Oral Lichen Planus
Azzam Almeshrafi, Arwa Alhamad, Arwa Alhamad, Arwa Alhamad, Arwa Alhamad, Hamoud AlKuraidees, Lubna AlNasser
Date Submitted: May 21, 2023
Open Peer Review Period: May 21, 2023 - Jul 16, 2023
Background: -
Objective: To explore and assess the quality of the Web-Based Health Information (WBHI) available and accessible to the public on
Oral Lichen Planus (OLP) in the Arabic language.
Methods: The Arabic translation of the term OLP and its derivatives were searched in three general search platforms and the first
few hundred results of each platform were reviewed for inclusion. We excluded content related to cutaneous LP, content not readily
accessible to the public (e.g., requiring subscription fees, directed to healthcare providers), and content not created by
healthcare providers or organizations (i.e., community forums, blogs, and social media). We assessed the quality of the Arabic
WBHI with three standardized and validated tools: DISCERN, JAMA benchmarks, and Health on the Net (HON).
Results: Out of 911 resources of WBHI reviewed for eligibility, 49 were included in this study. Most WBHI resources were provided
by commercial affiliations (57.1%), followed by not-for-profit affiliations (38.8%). WBHI on OLP are mostly presented with visual
aids (i.e., images) (66%). Less than one-quarter of the WBHI resources (22.4%) met all four JAMA benchmarks, indicating full
accountability of the WBHI’s providers. The DISCERN scores were highest for explicitly providing the aims of the WBHI resource
while the lowest scores were noted for providing the effect of OLP (or OLP treatment) on the quality of life. HON scores showed
the almost one-third of WBHI sources had scores above 70%, indicating higher reliability and credibility of the source, while
one-fifth of the sources scored below 50%.
Conclusions: There are considerable variations in the quality of WBHI on OLP in Arabic, with majority of WBHI resources showing
unfavorable scores on the quality assessment tools. Improved reporting of authors, updates, and references of WBHI will improve
the quality and reliability of these OLP resources; and potentially, their utility and benefit to the public seeking WBHI on OLP
in Arabic.
add me as a reviewer Facebook Twitter
The Toronto Tele-Retinal Screening Program for the Elderly in Long-Term Care: A Pilot Project
Michelle Lim, Tina Felfeli, Winnie Mangubat, Hamid Moghimi, Michael Grinton, Michael H. Brent
Date Submitted: May 21, 2023
Open Peer Review Period: May 20, 2023 - Jul 15, 2023
Background: Mobility challenges, transportation, and finances may serve as barriers to diabetic retinopathy (DR) screening in the
growing elderly population in Ontario. Screening of patients in their own nursing homes using teleophthalmology may improve
accessibility to DR screening.
Objective: To report the feasibility, results, and patient satisfaction of a pilot expansion of the Toronto Tele-Retinal Screening
Program in an elderly long-term care home.
Methods: A pilot project was initiated with a cohort of elderly patients with Type II diabetes mellitus (DM) in long-term care who
were referred to the Toronto Tele-Retinal Screening Program for DR screening between April 1, 2022 and July 1, 2022.
Results: A total of 28 patients were screened for DR. Half (14/28) of patients suffered from a fall within the last year and 35%
(10/28) were fully dependent for mobility. Overall, 14.3% (4/28) of patients could not be successfully imaged. Of the patients
imaged, 8.3% (2/24) were advised to arrange an urgent follow-up. Pathologies identified included uncontrolled glaucoma (4.1%,
1/24), non-proliferative DR (NPDR) (8.3%, 2/24), wet age-related macular degeneration (AMD) (8.3%, 2/24), and dry AMD (37.5%,
9/24). A total of 20.8% (5/24) patients could not undergo tabletop imaging due to mobility issues. Screening of 60% (3/5) of these
patients were successful with the handheld camera. Overall, 90% (17/19) of patients rated their subjective screening experience as
either “brilliant” or “really good.”
Conclusions: This pilot project demonstrated that the implementation of the Toronto Tele-Retinal Screening Program into elderly
long-term care homes may mitigate common barriers to eye screening with a good subjective patient experience.
add me as a reviewer Facebook Twitter
Your username is and your email address is [email protected]. We do not have your ORCID on file - please register for one at
Please login at
To submit your paper to JMIR Dermatology or another JMIR journal, go to
Submit Paper
Subscribed: Journal Journal of Medical Internet Research JMIR Research Protocols JMIR mHealth and uHealth interactive Journal of
Medical Research JMIR Medical Informatics JMIR Public Health and Surveillance JMIR Mental Health JMIR Human Factors JMIR Serious
Games Medicine 2.0 JMIR Medical Education JMIR Cancer Iproceedings JMIR Rehabilitation and Assistive Technologies JMIR Diabetes
JMIR Preprints JMIR Challenges JMIR Bioinformatics and Biotechnology JMIR Biomedical Engineering JMIR Data JMIR Cardio Journal of
Participatory Medicine JMIR Formative Research JMIR Dermatology JMIR Pediatrics and Parenting JMIR Aging JMIR Perioperative
Medicine
Copyright © 2023 JMIR Publications Inc, All rights reserved.
Our mailing address is:
JMIR Publications Inc
130 Queens Quay East
Suite 1100-1102
Toronto, Ontario M5A 0P6
Canada
Add us to your address book
This email was sent to [email protected]
why did I get this?
JMIR Publications Inc · 130 Queens Quay East · Suite 1100-1102 · Toronto, Ontario M5A 0P6 · Canada
Show all